EBC-129 is a first-in-class antibody drug conjugate (ADC) targeting a novel, tumor-specific N256-glycosylated epitope on CEACAM5 and CEACAM6. The updated findings showed promising efficacy data ...

NextPoint Therapeutics, a clinical-stage biotechnology company launching a new world of precision therapeutics through its leading scientific work on the nov ...

Vaxcyte's VAX-24 Phase 2 trial showed a safety profile similar to PCV20, with strong immune responses and no serious vaccine-related adverse events.

Researchers have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results, the approach combined the benefits ...

Pfizer doubles down on AI partnership with antibody-drug conjugate deal Artificial intelligence start-up PostEra will help the drugmaker design new payloads by Rowan Walrath January 7, 2025 ...

At the heart of the Westside Barbell method is the conjugate system, which rotates exercises to prevent ‘accommodation’ – a lifting term for stagnation in your training and your strength ...

AstraZeneca on Monday unveiled plans to build a $1.5 billion antibody-drug conjugate manufacturing facility in Singapore.

BE’s 14-Valent Pneumococcal Conjugate Vaccine: Phase III trials prove ‘safety’ Pneubevax14 was found to be safe and induced robust and functional serotype specific immune responses to all 14 ...

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study.

Immunome, Inc. (Nasdaq: IMNM) and Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), today announced that they have entered into an exclusive, worldwide license ...